Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age
Clinical trial NCT01768117 · COMPLETED
Trial details
- NCT number
- NCT01768117
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.